ANDA 211130, held by Apotex Inc. Vortioxetine Hydrobromide.
As of Nov 16, 2026, ANDA 211130 (Vortioxetine Hydrobromide), held by Apotex Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 29, 2026 | Original application | Tentative approval | None posted |
| Vortioxetine Hydrobromide10MG · tablet | Vortioxetine Hydrobromide | None (tentative approval) |
| Vortioxetine Hydrobromide15MG · tablet | Vortioxetine Hydrobromide | None (tentative approval) |
| Vortioxetine Hydrobromide5MG · tablet | Vortioxetine Hydrobromide | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters